Sep 30
|
Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial
|
Aug 26
|
Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
Jul 29
|
Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting
|
Jul 26
|
We're Hopeful That Anixa Biosciences (NASDAQ:ANIX) Will Use Its Cash Wisely
|
Jul 23
|
Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy
|
Jul 23
|
EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy
|
Jun 24
|
Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial
|
May 9
|
Anixa expands cancer vaccine collaboration with Cleveland Clinic
|
May 8
|
Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines
|
May 7
|
Sidoti Events, LLC's Virtual May Micro-Cap Conference
|
May 6
|
Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja
|
Apr 30
|
Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024
|
Apr 18
|
Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
|
Mar 14
|
Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
|
Mar 11
|
Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
|
Jan 23
|
Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology
|
Jan 16
|
Sidoti Events, LLC's Virtual January Micro-Cap Conference
|
Jan 10
|
Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024
|
Dec 14
|
Anixa Biosciences to Present at Biotech Showcase 2024
|
Dec 6
|
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
|